No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis

by Shaw, F L, Kimber, I, Begum, R, Cumberbatch, M, Dearman, R J, Griffiths, C E M
Published 2012

What’s new in psoriasis treatment? An analysis of systematic reviews published in 2015

by Foulkes, A.C., Ferguson, F., Grindlay, D.J.C., Williams, H.C., Griffiths, C.E.M., Warren, R.B.
Published 2018

A novel mutation in IL36RN underpins childhood pustular dermatosis

by Ellingford, J.M., Black, G.C.M., Clayton, T.H., Judge, M., Griffiths, C.E.M., Warren, R.B.
Published 2015

Primary care‐based screening for cardiovascular risk factors in patients with psoriasis†

by Rutter, M.K., Kane, K., Lunt, M., Cordingley, L., Littlewood, A., Young, H.S., Chew‐Graham, C.A., Hilton, R., Symmons, D.P.M., Griffiths, C.E.M.
Published 2016

Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis

by Smith, Rh. Ll., Hébert, H. L., Massey, J., Bowes, J., Marzo-Ortega, H., Ho, P., McHugh, N. J., Worthington, J., Barton, A., Griffiths, C. E. M., Warren, R. B.
Published 2016